News

Currently Wegovy has a list price of around $1,350 for a 28-day supply. This means that the medication could cost more than ...
Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions - Novo ...
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
From a fundamental standpoint, Eli Lilly presently has a market capitalization of $789 billion. Over the trailing twelve ...
WW International shares are trading higher by 79% during Tuesday's session. The company announced a new partnership with Eli ...
The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own obesity medication.
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
WW International (NASDAQ:WW) stock surges with a new partnership to offer Eli Lilly's (LLY) weight-loss therapy Zepbound.
Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...